Notably, the inhibition of Dll4‐Notch signaling was recently shown to drive differentiation of insulin‐producing cell progenitors, induce β‐cell proliferation and confer protection against streptozotocin‐induced diabetes (Billiard et al., 2018). Here, DLL4 is linked to diabetes mellitus.